HCV and the hepatic lipid pathway as a potential treatment target

被引：52

作者：

Bassendine, Margaret F. ^{[1
]}

Sheridan, David A.

Felmlee, Daniel J.

Bridge, Simon H.

Toms, Geoffrey L.

Neely, R. Dermot G. ^{[2
]}

机构：

[1] Newcastle Univ, Inst Cellular Med, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England

[2] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Clin Biochem, Newcastle Upon Tyne, Tyne & Wear, England

来源：

JOURNAL OF HEPATOLOGY | 2011年 / 55卷 / 06期

基金：

英国医学研究理事会;

关键词：

Antiviral agents; Lipoproteins; Cholesterol; VLDL; Triglycerides; Hepatitis C; Chronic; SCAVENGER RECEPTOR BI; LOW-DENSITY-LIPOPROTEIN; DOUBLE-FILTRATION PLASMAPHERESIS; APOLIPOPROTEIN-C-III; PEGYLATED INTERFERON ALPHA-2A; NONSTRUCTURAL PROTEIN 5A; VIRUS-RNA REPLICATION; IN-VIVO; INSULIN-RESISTANCE; VIROLOGICAL RESPONSE;

D O I：

10.1016/j.jhep.2011.06.004

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

收藏

页码：1428 / 1440

页数：13

相关论文

共 168 条

[71] Apolipoprotein CIII Links Dyslipidemia with Atherosclerosis [J].

Kawakami, Akio ;

Yoshida, Masayuki .

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2009, 16 (01) :6-11

[72] Pioglitazone improves virological response to peginterferon α-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance [J].

Khattab, Mahmoud ;

Emad, Mohammed ;

Abdelaleem, Asharf ;

Eslam, Mohammed ;

Atef, Rabab ;

Shaker, Yehia ;

Hamdy, Lamia .

LIVER INTERNATIONAL, 2010, 30 (03) :447-454

[73] Double-Filtration Plasmapheresis plus IFN for HCV-1b Patients with Non-Sustained Virological Response to Previous Combination Therapy: Early Viral Dynamics [J].

Kim, Soo Ryang ;

Imoto, Susumu ;

Kudo, Masatoshi ;

Mita, Keiji ;

Taniguchi, Miyuki ;

Kim, Ke Ih ;

Sasase, Noriko ;

Shoji, Ikuo ;

Nagano-Fujii, Motoko ;

El-Shamy, Ahmed ;

Hotta, Hak ;

Nagai, Tomoyuki ;

Nagata, Yoshiaki ;

Hayashi, Yoshitake .

INTERVIROLOGY, 2010, 53 (01) :44-48

[74] ACTIVATION OF LIPOPROTEIN-LIPASE BY NATIVE AND SYNTHETIC FRAGMENTS OF HUMAN-PLASMA APOLIPOPROTEIN C-II [J].

KINNUNEN, PKJ ;

JACKSON, RL ;

SMITH, LC ;

GOTTO, AM ;

SPARROW, JT .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (11) :4848-4851

[75] Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT [J].

Kypreos, Kyriakos E. ;

Zannis, Vassilis I. .

BIOCHEMICAL JOURNAL, 2007, 403 (359-367) :359-367

[76] Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection [J].

Lanford, Robert E. ;

Hildebrandt-Eriksen, Elisabeth S. ;

Petri, Andreas ;

Persson, Robert ;

Lindow, Morten ;

Munk, Martin E. ;

Kauppinen, Sakari ;

Orum, Henrik .

SCIENCE, 2010, 327 (5962) :198-201

[77] Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapy [J].

Lange, C. M. ;

Sarrazin, C. ;

Zeuzem, S. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (01) :14-28

[78] Development of novel therapies for hepatitis C [J].

Lemon, Stanley M. ;

McKeating, Jane A. ;

Pietschmann, Thomas ;

Frick, David N. ;

Glenn, Jeffrey S. ;

Tellinghuisen, Timothy L. ;

Symons, Julian ;

Furman, Phillip A. .

ANTIVIRAL RESEARCH, 2010, 86 (01) :79-92

[79] Anti-HCV activities of selective polyunsaturated fatty acids [J].

Leu, GZ ;

Lin, TY ;

Hsu, JTA .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 318 (01) :275-280

[80] Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro [J].

Lindenbach, BD ;

Meuleman, P ;

Ploss, A ;

Vanwolleghem, T ;

Syder, AJ ;

McKeating, JA ;

Lanford, RE ;

Feinstone, SM ;

Major, ME ;

Leroux-Roels, G ;

Rice, CM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (10) :3805-3809

← 3 4 5 6 7 8 9 10 11 12 →